Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideABTAbbott Laboratories
FinDog View：Neutral
MDTMedtronic
FinDog View：Bullish
| Metric | ABT | MDT |
|---|
| Close | 106.20 | 96.54 |
| Market Cap | $184B | $124B |
| 1M | +7.46% | +11.88% |
| P/E (TTM) | 39.1 | 23.8 |
| Forward P/E | 17.6 | 14.8 |
| P/E 5-Yr Percentile | 99 | 14 |
| P/S | 3.8 | 3.3 |
| P/B | 3.6 | 2.5 |
| Dividend Yield | 1.98% | 3.50% |
| Latest Quarter Revenue | $11.2B | $9.8B |
| Revenue YoY | +7.8% | +13.7% |
| Gross Margin | 56.2% | 65.0% |
| Latest Quarter EPS | 0.61 | 1.14 |
| Avg Post-Earnings Move | ±1.6% | ±2.6% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.71% | 3.89% |
| 90-Day Net Insider Buying | −$46.9M | −$5.9M |
ABT · Revenue, Last 8 Quarters ($B)
MDT · Revenue, Last 8 Quarters ($B)
